3T Biosciences IPO

www.3tbiosciences.comHealthcare / BioTech & Pharma

3T Biosciences is a medical research and drug development company. Targeting T-cell-mediated diseases such as cancer, 3T Biosciences has a mission to create new treatments for patients by incorporating machine learning and synthetic biology. The company uses its T-cell science methodology to address concerns with immunotherapy with treatment that is less invasive. 3T Biosciences was founded by Leah Sibener, Luke Lee, and Marvin Gee in 2017 and is headquartered in San Francisco, CA.

Buy or sell 3T Biosciences stock Learn more about 3T Biosciences stock

Learn more about 3T Biosciences

Is 3T Biosciences a publicly traded company?

3T Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Will 3T Biosciences go IPO?

3T Biosciences has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is 3T Biosciences's IPO price?

The IPO price for 3T Biosciences will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.

Can you invest in 3T Biosciences pre-IPO?

3T Biosciences is privately held company and is not publicly traded, therefor investing in 3T Biosciences pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

What is the value of my 3T Biosciences shares?

To determine the value of your 3T Biosciences shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your 3T Biosciences shares. You can also learn more about how to sell your private shares before getting started.

Can you sell 3T Biosciences before it goes public?

Yes, you can seek to sell shares in 3T Biosciences while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

When was 3T Biosciences founded?

3T Biosciences was founded in 2017.

Who are 3T Biosciences's major investors?

Lightspeed Venture Partners

Menlo Ventures

CRV

Starlight Ventures

Westlake Village BioPartners

Johnson & Johnson Innovation

Thiel Capital

Asset Management Ventures

Hayan Health Networks

Parker Institute for Cancer Immunotherapy

OS Fund

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.